Glioma-Associated Antigen Peptide-Pulsed Autologous Dendritic Cell Vaccine
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer CentervaccinePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
48 Active assets in the Brain and Central Nervous System Tumors cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Procarbazine Universitätsmedizin Mannheim | Phase 3 | BBB |
VINCRISTINE SULFATE Northwestern University | Phase 3 | BBB |
Irinotecan EpicentRx, Inc. | Phase 2 | BBB |
ETOPOSIDE NewLink Genetics Corporation | Phase 3 | BBB |
Gefetinib Memorial Sloan Kettering Cancer Center | Phase 2 | BBB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →